2BB score and signals
Vivos Therapeutics, Inc.’s current 2BB score is 28 out of 100, built from the signal categories below.
| Signal | Score | Reading |
|---|
| Activity | 10 | Very Low |
| Momentum | 42 | Stable |
| Financial strength | 18 | Very Weak |
| Quality | 100 | Very Strong |
| Risk | 61 | High |
Company facts
| Headquarters | Littleton, Colorado, United States |
| Founded | 2016 |
| Employees | 270 |
| 52-week range | $0.27 – $5.11 |
Recent earnings
| Report date | EPS actual | EPS estimate | Revenue actual | Revenue estimate |
|---|
| 2026-11-17 | — | -0.3094 | — | $6.11M |
| 2026-08-17 | — | -0.3944 | — | $5.47M |
| 2026-05-20 | -0.52 | -0.4624 | $5.14M | $4.31M |
| 2026-04-15 | -0.58 | -0.493 | $3.82M | $6.58M |
Related companies